Q10 PLUS 90 CAPS

Q10 Plus ist eine Formel, die auf besondere Weise entwickelt wurde, um den Körper zu stärken und die Blutbildung zu fördern. Q10 Plus enthält neben dem Co-Enzym Q10 auch Taurin, Crataegus oxyacantha (tweestijlige meidoorn), Magnesium, Ginkgo biloba und Lmethionin. Hartweefsel enthält hohe Konzentrationen an Taurin. De bessen en bloesems van tweestijlige meidoorn worden al sinds eeuwen gebruikt om de hartfunctie te verzorgen. Crateagus oxycantha wirkt verkwikkend für den Hart, ist gunstig für den Blutegel und houdt den normalen Blutegel in Stand. Magnesium is zeer belangrijk voor het in stand houden van de cardiovascular gezondheid. Ginkgo biloba optimiert sowohl die perifere als auch die arterielle Doorbloeding. L-Methionin ist ein lipotroper Aminozuur.

1 Kapsel pro Tag of zoals aanbevolen

1. Degenring FH, Suter A, Weber M, Saller R A randomised double blind placebo controlled clinical trial of a standardised extract of fresh
   Crataegus-Beeren (Crataegisan) zur Behandlung von Patienten mit kongestiver
   heart failure NYHA II.Phytomedicine. 2003;10(5):363-9.

2. Schaffer S, Solodushko V, Pastukh V, Ricci C, Azuma J Possible Cause
   of Taurine-deficient Cardiomyopathy: Potentiation of Angiotensin II Action. J
   Cardiovasc Pharmacol. 2003 May;41(5):751-9

3. Takahashi K, Ohyabu Y, Takahashi K, Solodushko V, Takatani T, Itoh T,
   Schaffer SW, Azuma J. Taurin macht die Zelle resistent gegen ischemia-induzierte
   injury in cultured neonatal rat cardiomyocytes.J Cardiovasc Pharmacol. 2003
   May;41(5):726-33.

4. Sarter B Coenzyme Q10 and cardiovascular disease: a review. J
   Cardiovasc Nurs. 2002 Jul;16(4):9-20. Review.

5. Atar D, Mortensen S.A., Flachs H, Herzog W.R. Coenzyme Q10 Protects
   Ischemic Myocardium in an Open-Chest Swine Model. Clin. Investig. 1993, 71
   :S103-S111.

6. Baggio E., Gandini R., Plancher C., Passeri N., Carmosino G. Italian
   Multi-Centre Study on the Safety and Efficacy of Coenzyme Q10 as Adjuvant
   Therapy in Heart Failure. Clin. Investig. 1993, 71:S145-S149.

7. di Palma A., Masini M., Cimatti G., Adamanti S., et al. Coenzym Q10
   : a probable longevity marker. Biomed. And Clin. Aspects of Q10, 6:489-
   492, 1991.

8. Hanaki Y., Sugiyama S., Ozawa T., Ohno M. Coenzym Q10 and Coronary Artery
   Artery Disease. Clin. Investig., 1993, 71:S112- S115.

9. Judy W.V., Stogsdill W.W., Folkers K. Myocardial Preservation by
   Therapy With Coenzyme Q10 During Heart Surgery. Clin. Investig. 1993, 71
   :S155-S161.

10. Kamei M., Fujita T., Kanbe T., Saski K., et al. The distribution and their distribution
    content of ubiquinone in foods. Int. J. Vitam. Nutr. Res., 56:1:57-63,

12. Kuklinski B., von Appen S., Weissenbacher E. Coenzyme Q10 and
    Antioxidants in Acute Myocardial Infarction. 8th Int. Symp. Biomed. and
    Cln. Aspects of CoQ10, 1993, s. 32.

13. Mordente A., Martorana G.E., Santini S.A., Miggiano G.A.D.
    Antioxidant Effect of Coenzyme Q10 on Hydrogen Peroxide-activated Myoglobin.
    Clin. Investig., 1993, 71:S92-S96.

14. Morisco C., Trimarco B., Condorelli M. Effect of Coenzyme Q10 Therapy
    in Patients with Congestive Heart Failure: A Long Term Multi-Centre
    Randomized Study. Clin. Investig., 1993, 71:S134- S136.

15. Mortensen S.A., Vadhanavikit S., Muratsu K., Folkers K. CoQ10:
    Clinical benefits with biochem. Correlates suggesting a break through in the
    management of chronic heart failure. Int. J. Tiss. Reac. : 12 :3 :155-162,

17. Sugimoto M., Ideta T., Imanishi K., Ono T., et al. Effect of CoQ10 in
    patienten mit progressiver Muskeldystrophie und anderen neuromuskulären Erkrankungen
    diseases. Biomed. and Clin. Aspects of CoQ10. 1:243-250, 1984.

18. Wilkinson E.G., Arnold R.M., Folkers K. Treatment of periodontal and
    other soft tissue diseases of the oral cavity with coenzym Q. Biomed. and
    Clin. Aspects of CoQ10, 1:251:266, 1977.

19. Yamagami T., Takagi M., Akagami H., Folkers K. Effect on Q10 on
    essential hypertension, a double blind controlled study. Biomed. and Clin.
    Aspects of CoQ10. 5 :337-344, 1986.

20. Zeppilli P., Merlino B., de Luca A., Littaru G.P., et al. Influence
    of CoQ10 on physical work capacity of athletes, sedentary people and patients
    with mitochondrial disease. Biomed. and Clin. Aspects of Q10.

Niet te gebruiken bij: geen gevallen gekend.

INHALTSSTOFFE PRO KAPSEL
Taurin	300 mg
Tweestijlige meidoorn (Crataegus oxyacantha)	100 mg
Magnesiumcitraat	80 mg
Kaliumcitraat	30 mg
Ginkgo biloba-extract (24% conc.)	20 mg
Co-Enzym Q10 (Ubichinon)	10 mg
L-Methionin	250 µg
Hulpstoffe: Gelatine, Mikrokristalline Zellulose, Magnesiumstearat *%RI = Referentie Inname (E.C.)